secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001438133-21-000194
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes Q3 sales $179.6M (+45% YoY); raises FY2021 sales guidance to $685-695M
--------------------------------------------------------------------------------

- Q3 sales $179.6M (+45% YoY); net income $5.8M vs loss $9.4M; adjusted EBITDA $26.9M (15% of sales).
- Worldwide pump shipments up 43% to 31,558; international shipments up 209% to 11,262.
- Full-year 2021 sales guidance raised to $685-695M from $670-685M; international guidance raised to $168-173M.
- Cash balance $595M, up $110M since Dec 2020; gross margin improved to 54% from 53%.
- Virtual R&D Day scheduled for December 6, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813321000194/0001438133-21-000194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813321000194/tndm-20211103.htm
  HTML page:      https://secwatch.observer/filing/0001438133-21-000194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer